Prediction of short-acting beta-agonist usage in patients with asthma using temporal-convolutional neural networks.

Nicholas HironsAngier AllenNoah MatsuyoshiJason SuLeanne KayeMeredith A Barrett

Published in: JAMIA open (2023)

Predicted SABA use may serve as a valuable forward-looking signal to inform early clinical intervention and self-management. Further validation with known exacerbation events is needed.

Keyphrases

convolutional neural network
chronic obstructive pulmonary disease
deep learning
randomized controlled trial
lung function
intensive care unit
machine learning
extracorporeal membrane oxygenation